Condition
Small Gestational Age (SGA)
Total Trials
3
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 3 (1)
Trial Status
Completed2
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT07731165Not ApplicableCompletedPrimary
Glycemic Variability During Pregnancy After Bariatric Surgery
NCT07143825Recruiting
A National Multicenter Survey on Small Vulnerable Newborns
NCT00249821Phase 3CompletedPrimary
Optimization of the Dosage Regimen of Growth Hormone Therapy in Children Born Small for Gestational Age
Showing all 3 trials